• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在高表达 CD133-人源的乙型肝炎病毒相关性肝细胞癌中,侵袭和 EMT 相关基因上调及细胞培养研究。

Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.

机构信息

Department of Pathology, Center for Chronic Metabolic Disease, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemoon-gu, Seoul 120-752, Republic of Korea.

出版信息

Exp Mol Pathol. 2011 Feb;90(1):66-73. doi: 10.1016/j.yexmp.2010.10.003. Epub 2010 Oct 20.

DOI:10.1016/j.yexmp.2010.10.003
PMID:20969862
Abstract

Hepatocellular carcinomas (HCCs) with expression of stem/progenitor cell markers including CD133 have been reported to have more aggressive biological behavior, and epithelial-mesenchymal transition (EMT), closely related invasion, has been suggested to generate cancer stem cells. To elucidate biological characteristics of HCCs expressing CD133, we evaluated migration assay and the mRNA expression levels of CD133, invasion-associated genes [urokinase plasminogen activator receptor (uPAR), villin 2 (VIL2), and MMP1 and MMP2], and EMT regulators (Snail, Slug, Twist, E-cadherin, and N-cadherin) by real-time PCR in HCC cell lines including HepG2, Hep3B, Huh7, PLC/RFP/6, SNU423, SNU449, and SNU475. Same genes and pathological features were also investigated in 49 samples of hepatitis B virus-related human HCCs. In all HCC cell lines studied, CD133-positive cells showed higher cell migration activity and up-regulated invasion- and EMT-associated genes with increased N-cadherin and decreased E-cadherin expressions compared to CD133-negative cells. The human HCCs were divided into the CD133-high group (top 40%) and the CD133-low group (bottom 40%) according to the level of CD133 mRNA. The CD133-high group showed relatively frequent vascular invasion and significantly higher expression of invasion-associated genes [uPAR (p=0.002), MMP1 (p=0.01), and MMP2 (p=0.003)] and EMT regulators [Snail (p=0.002) and Twist (p=0.0003)] compared to the CD133-low group. In conclusion, our results suggest that there is a subtype of HCC with high expression of CD133, which might have more invasive characteristics by up-regulation of invasion-associated genes and EMT-associated genes.

摘要

肝细胞癌 (HCCs) 表达干细胞/祖细胞标志物,包括 CD133,已被报道具有更具侵袭性的生物学行为,上皮-间充质转化 (EMT) 与侵袭密切相关,被认为产生癌症干细胞。为了阐明表达 CD133 的 HCC 的生物学特性,我们通过实时 PCR 评估了迁移试验以及 HCC 细胞系 [尿激酶纤溶酶原激活物受体 (uPAR)、villin 2 (VIL2)、MMP1 和 MMP2] 和 EMT 调节剂 (Snail、Slug、Twist、E-钙粘蛋白和 N-钙粘蛋白) 的 CD133 表达水平,包括 HepG2、Hep3B、Huh7、PLC/RFP/6、SNU423、SNU449 和 SNU475。在 49 例乙型肝炎病毒相关人类 HCC 样本中也研究了相同的基因和病理特征。在所有研究的 HCC 细胞系中,与 CD133-阴性细胞相比,CD133 阳性细胞表现出更高的细胞迁移活性,并上调了侵袭和 EMT 相关基因,同时表达了更多的 N-钙粘蛋白和更少的 E-钙粘蛋白。根据 CD133 mRNA 水平,将人 HCC 分为 CD133-高组 (前 40%) 和 CD133-低组 (后 40%)。与 CD133-低组相比,CD133-高组表现出相对频繁的血管侵犯,侵袭相关基因 [uPAR(p=0.002)、MMP1(p=0.01) 和 MMP2(p=0.003)] 和 EMT 调节剂 [Snail(p=0.002) 和 Twist(p=0.0003)] 的表达显著更高。总之,我们的结果表明,存在一种 CD133 高表达的 HCC 亚型,通过上调侵袭相关基因和 EMT 相关基因,可能具有更具侵袭性的特征。

相似文献

1
Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study.在高表达 CD133-人源的乙型肝炎病毒相关性肝细胞癌中,侵袭和 EMT 相关基因上调及细胞培养研究。
Exp Mol Pathol. 2011 Feb;90(1):66-73. doi: 10.1016/j.yexmp.2010.10.003. Epub 2010 Oct 20.
2
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.具有“干性”相关标志物表达的人肝细胞癌:角蛋白 19 的表达与预后不良相关。
Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.
3
Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.上皮-间质转化调控因子 Twist1 通过基质金属蛋白酶的激活促进肝癌转移。
J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.
4
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.Runt 相关转录因子 3 逆转肝癌中的上皮-间充质转化。
Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24.
5
[CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].[CD133通过上皮-间质转化促进胃癌的侵袭和转移]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jul;16(7):662-7.
6
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.Twist和Snail在促进肝细胞癌转移中独立作用的综合分析。
Hepatology. 2009 Nov;50(5):1464-74. doi: 10.1002/hep.23221.
7
Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.ATOH8 的缺失增加了肝癌细胞的干细胞特征。
Gastroenterology. 2015 Oct;149(4):1068-81.e5. doi: 10.1053/j.gastro.2015.06.010. Epub 2015 Jun 20.
8
Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.长链非编码RNA SPRY4-IT1的过表达通过激活肝细胞癌中的EZH2促进肿瘤细胞增殖和侵袭。
Biomed Pharmacother. 2017 Jan;85:348-354. doi: 10.1016/j.biopha.2016.11.035. Epub 2016 Nov 28.
9
Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.CD133 的表达通过调节人肝癌中的金属蛋白酶赋予恶性潜能。
J Hepatol. 2010 Jun;52(6):872-9. doi: 10.1016/j.jhep.2009.12.030. Epub 2010 Mar 24.
10
miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.微小RNA-27a-3p通过下调血管内皮钙黏蛋白表达和抑制上皮-间质转化来抑制肿瘤转移和血管生成拟态:Twist-1在肝癌中的重要作用
Sci Rep. 2016 Mar 16;6:23091. doi: 10.1038/srep23091.

引用本文的文献

1
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.
2
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.尿激酶受体信号传导对细胞功能的调节:一种机制性观点
Front Cell Dev Biol. 2022 Apr 8;10:818616. doi: 10.3389/fcell.2022.818616. eCollection 2022.
3
The role of CD133 in hepatocellular carcinoma.
CD133 在肝细胞癌中的作用。
Cancer Biol Ther. 2021 Apr 3;22(4):291-300. doi: 10.1080/15384047.2021.1916381. Epub 2021 Apr 25.
4
Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines.西罗莫司和霉酚酸酯作为免疫抑制剂,在调控肝癌细胞系中CD133+EpCAM+细胞群的增殖方面作用不足。
Biomed Rep. 2020 Dec;13(6):69. doi: 10.3892/br.2020.1376. Epub 2020 Oct 20.
5
Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.代谢重编程与上皮-间质可塑性:癌症治疗的机遇与挑战
Front Oncol. 2020 May 20;10:792. doi: 10.3389/fonc.2020.00792. eCollection 2020.
6
Models for Understanding Resistance to Chemotherapy in Liver Cancer.理解肝癌化疗耐药性的模型
Cancers (Basel). 2019 Oct 29;11(11):1677. doi: 10.3390/cancers11111677.
7
Role of Metabolic Reprogramming in Epithelial⁻Mesenchymal Transition (EMT).代谢重编程在上皮-间充质转化(EMT)中的作用。
Int J Mol Sci. 2019 Apr 25;20(8):2042. doi: 10.3390/ijms20082042.
8
STAT3 in hepatocellular carcinoma: new perspectives.肝细胞癌中的信号转导与转录激活因子3:新视角
Hepat Oncol. 2014 Jan;1(1):107-120. doi: 10.2217/hep.13.7. Epub 2013 Dec 20.
9
mediates the role of Lethal giant larvae as an epithelial growth inhibitor in .介导致死性巨幼虫作为上皮生长抑制剂在……中的作用。
Biol Open. 2018 Jan 26;7(1):bio027391. doi: 10.1242/bio.027391.
10
Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells.沙利度胺通过调节胰腺癌细胞中CD133的表达来抑制增殖和上皮-间质转化。
Oncol Lett. 2017 Dec;14(6):8206-8212. doi: 10.3892/ol.2017.7213. Epub 2017 Oct 18.